Why is Brooks Lab. falling/rising?

As of 22-Aug, Brooks Laboratories Ltd's stock price is currently at 145.60, reflecting an increase of 0.6 or 0.41%. The stock has shown a trend reversal, gaining after two consecutive days of decline. However, it has experienced a significant drop of 4.96% over the past week and 7.29% over the past month. Despite these short-term challenges, the company has reported very positive results, including a remarkable 97.76% growth in net profit and consistent positive results over the last three quarters. Additionally, the company has seen a substantial decrease in raw material costs, which fell by 88.66% year-over-year. However, the stock's long-term fundamental strength is weak, with an average return on equity of 0% and poor growth in net sales.
In the broader market context, while the Sensex has gained 0.88% over the past week, Brooks Laboratories Ltd has underperformed with a decline of 4.96%. Despite this, the stock has outperformed the broader market over the past year, generating a return of 11.93% compared to the Sensex's 0.31%. The stock's liquidity remains adequate for trading, but there has been a notable decline in investor participation, with delivery volume dropping by 55.54% against the five-day average. This combination of factors suggests that while the stock has some positive attributes, its recent performance is hindered by weak long-term fundamentals and declining investor interest.